For localized information and support, would you like to switch to your country-specific website for {0}?
- Insights
- Dermatopathology IHC/ISH solutions
Driving diagnostic certainty with dermatopathology IHC/ISH solutions
Melanoma is a malignancy of the melanocytes, and histology is the gold standard for distinguishing malignant cells from benign cells1. We offer over 50 cornerstone and novel dermatopathology ready-to-use reagents, including key IHC and FITC antibodies, which aid in melanoma diagnosis, basal cell carcinoma diagnosis, squamous cell carcinoma diagnosis and diagnosis of other dermatological malignancies.
Our robust menu of tools aid in dermatopathology diagnostics and treatment. Our portfolio of immunohistochemistry detection products delivers the high sensitivity and specificity you need from your assays. Our antibodies are ready-to-use on the fully-automated VENTANA BenchMark IHC/ISH staining platforms, reducing the time-to-result and resources required with manual or semi-automated solutions.
Oncology
Explore Roche solutions for life-changing decisions in oncology focused on overcoming challenges through innovation and optimizing outcomes in cancer care.
View now
Contact us
Do you have questions about our products or services? We’re here to help. Contact a Roche representative in your region.
Featured products and solutions
IVD
For in vitro diagnostic use.
SOX- 10 (SP267) Rabbit Monoclonal Primary Antibody
SOX-10 (SP267) Rabbit Monoclonal Primary Antibody is intended for laboratory use in the detection of the SOX-10 protein in formalin-fixed, paraffin-embedded tissue stained on BenchMark immunohistochemical (IHC/ISH) automated slide stainers. SOX-10 is a nuclear transcription factor that participates in neural crest development and in the specification and differentiation of cells of melanocytic lineage.2
SOX-10 (SP267) Rabbit Monoclonal Primary Antibody is intended for laboratory use in the detection of the SOX-10 protein in formalin-fixed, paraffin-embedded tissue stained on BenchMark immunohistochemical (IHC/ISH) automated slide stainers. SOX-10 is a nuclear transcription factor that participates in neural crest development and in the specification and differentiation of cells of melanocytic lineage.2
IVD
For in vitro diagnostic use.
CONFIRM anti-MART-1/melan A (A103) Mouse Monoclonal Primary Antibody
CONFIRM anti-MART-1/melan A (A103) Mouse Monoclonal Primary Antibody is a mouse monoclonal antibody (IgG1) directed against melan A. Positive staining may aid in the differentiation of melanoma.
CONFIRM anti-MART-1/melan A (A103) Mouse Monoclonal Primary Antibody is a mouse monoclonal antibody (IgG1) directed against melan A. Positive staining may aid in the differentiation of melanoma.
IVD
For in vitro diagnostic use.
Anti-PRAME (EPR20330) Rabbit Monoclonal Primary Antibody
The anti-PRAME (EPR20330) Rabbit Monoclonal Primary Antibody detects the overexpression of the tumor-associated antigen, PReferentially expressed Antigen in MElanoma (PRAME), in formalin-fixed paraffin embedded tissue. Positive staining may aid in the differentiation of benign versus malignant melanocytic lesions.4,5
The anti-PRAME (EPR20330) Rabbit Monoclonal Primary Antibody detects the overexpression of the tumor-associated antigen, PReferentially expressed Antigen in MElanoma (PRAME), in formalin-fixed paraffin embedded tissue. Positive staining may aid in the differentiation of benign versus malignant melanocytic lesions.4,5
...
Explore more
Contributors
Roche Diagnostics
Roche Diagnostics is a division of Roche, developing and integrating diagnostic solutions that address today’s healthcare challenges while anticipating tomorrow’s needs. In more than 100 countries, we provide one of the industry’s most comprehensive in vitro diagnostics portfolios spanning molecular diagnostics, clinical chemistry and immunoassays, tissue diagnostics, Point of Care testing, patient self-testing, next-generation sequencing, laboratory automation and IT, as well as digital health and decision-support solutions.
Our articles are authored by Roche Diagnostics subject matter experts, drawing on collective expertise across multiple disciplines to provide reliable insights for healthcare professionals worldwide.
Explore articles from our community
?wid=384&hei=216&fmt=png-alpha&fit=crop,1&cropn=0.07,0,0.86,1)
?wid=384&hei=216&fmt=png-alpha&fit=crop,1&cropn=0.07,0,0.86,1)
No insights found
Contact us
Do you have questions about our products or services? We’re here to help. Contact a Roche representative in your region.
References
- Damanpour, S. Grichnik, J. Conceptual approach to early melanoma detection: models, issues and challenges. Melanoma Manag. 2015 2 (4): 327-337.